Tellgen Corp
SZSE:300642
Intrinsic Value
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. [ Read More ]
The intrinsic value of one Tellgen Corp stock under the Base Case scenario is 25.43 CNY. Compared to the current market price of 12.73 CNY, Tellgen Corp is Undervalued by 50%.
Valuation Backtest
Tellgen Corp
Run backtest to discover the historical profit from buying and selling Tellgen Corp stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Tellgen Corp
Current Assets | 935.7m |
Cash & Short-Term Investments | 499.4m |
Receivables | 237.3m |
Other Current Assets | 199m |
Non-Current Assets | 722.6m |
Long-Term Investments | 283.1m |
PP&E | 277.1m |
Intangibles | 54.6m |
Other Non-Current Assets | 107.8m |
Current Liabilities | 134.8m |
Accounts Payable | 73.6m |
Accrued Liabilities | 8.6m |
Short-Term Debt | 4m |
Other Current Liabilities | 48.6m |
Non-Current Liabilities | 24.2m |
Long-Term Debt | 5.6m |
Other Non-Current Liabilities | 18.7m |
Earnings Waterfall
Tellgen Corp
Revenue
|
598.7m
CNY
|
Cost of Revenue
|
-230.8m
CNY
|
Gross Profit
|
367.9m
CNY
|
Operating Expenses
|
-322.4m
CNY
|
Operating Income
|
45.5m
CNY
|
Other Expenses
|
34.2m
CNY
|
Net Income
|
79.7m
CNY
|
Free Cash Flow Analysis
Tellgen Corp
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Tellgen Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Tellgen Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Tellgen Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Tellgen Corp's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Tellgen Corp
According to Wall Street analysts, the average 1-year price target for Tellgen Corp is 23 CNY .
Shareholder Return
Price
Tellgen Corp
Average Annual Return | -0.16% |
Standard Deviation of Annual Returns | 28.37% |
Max Drawdown | -85% |
Market Capitalization | 2.1B CNY |
Shares Outstanding | 164 206 241 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 810 full-time employees. The company went IPO on 2017-04-21. The firm's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
Contact
IPO
Employees
Officers
The intrinsic value of one Tellgen Corp stock under the Base Case scenario is 25.43 CNY.
Compared to the current market price of 12.73 CNY, Tellgen Corp is Undervalued by 50%.